What is Pemetrexed?

Category: Prescription Drugs

Most popular types: Alimta


Pemetrexed is an anticancer drug used to treat malignant pleural mesothelioma and nonsquamous nonsmall cell lung cancer. It has also been used for bladder, cervical, ovarian cancer and thymic cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 5
Mild 3
None 2

Commonly reported side effects and conditions associated with Pemetrexed

Side effect Patients
Chronic fatigue 1
Fatigue 1
Hair loss 1
Nausea 1
Pressure headaches 1


Based on patients currently taking Pemetrexed

Dosage Patients
100 mg every 3 weeks 1

Why patients stopped taking Pemetrexed

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
Doctor's advice 1
See all 2 patients who've stopped taking Pemetrexed


Currently taking Pemetrexed

Duration Patients
2 - 5 years 1

Stopped taking Pemetrexed

Duration Patients
1 - 6 months 1
6 months - 1 year 1
Adherence Evaluations
Always 6
Usually 1
Sometimes 0
Never taken as prescribed 3
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 4
Not at all hard to take 3
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 9

What people switch to and from

Patients started taking Pemetrexed after stopping:

Treatment Patients
Bevacizumab (Avastin) 1
Chemotherapy 1
Pemetrexed-carboplatin chemotherapy 1

Patients stopped taking Pemetrexed and switched to:

Treatment Patients
Docetaxel (Taxotere) 1
Gefitinib (Iressa) 1
Ramucirumab (Cyramza) 1
Last updated:
There are no evaluations for Pemetrexed.